Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C (HIVCOBOC-RGT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2013 by Medical University of Vienna.
Recruitment status was  Recruiting
Medical University of Vienna
Information provided by (Responsible Party):
Markus Peck-Radosavljevic, Medical University of Vienna Identifier:
First received: August 15, 2013
Last updated: August 16, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)